3 Small-Cap Stocks With Big Potential
“While one could argue that small cap stocks are a bit riskier than large, well-funded behemoths, they’re also the place to look for the next…
“While one could argue that small cap stocks are a bit riskier than large, well-funded behemoths, they’re also the place to look for the next…
Historically, January and February tend to be very strong months for biotech, while March tends to be very weak. But, with COVID-19 continuing to bear…
As the economic recovery continues, Goldman Sachs is advising investors to “balance the appeal of promising businesses with the risk that [interest] rates rise further…
When it comes to the first requirement to be a successful trend trader, the author of today’s article advises “You need to follow the ‘smart…
What’s to love about trading options? Quite a bit! From reducing risk, to providing the flexibility to react to market volatility, to achieving consistent returns…
A huge opportunity exists for a group of biotech stocks seeking to “hijack the immune system” with bispecific antibodies. Just what are bispecific antibodies –…
If stronger-than-expected fourth-quarter earnings, the prospect of massive government stimulus, and accelerating vaccine distribution has you feeling bullish, a perfect bet right now may be…
This previously little-known immunotherapy stock recently saw its shares soar nearly 249% — and its market value surge from $300 million to more than $1…
Assessing the current state of the biotech industry, the author of today’s article notes that “While the coronavirus treatments will take center stage in 2021,…
Investing in bitcoin has become a hot topic over the last few years, as has investing in the technology behind bitcoin and other cryptocurrencies: blockchain.…